Stockscreener 앱 받기
0.63
41.10%
0.1835
시간 외 거래:
.63
전일 마감가:
$0.4465
열려 있는:
$0.5732
하루 거래량:
306.72M
Relative Volume:
57.46
시가총액:
$28.05M
수익:
$106.79M
순이익/손실:
$-8.73M
주가수익비율:
-3.15
EPS:
-0.2
순현금흐름:
$10.81M
1주 성능:
+56.02%
1개월 성능:
+43.25%
6개월 성능:
+70.32%
1년 성능:
-74.29%
1일 변동 폭
$0.5235
$0.94
1주일 범위
$0.3952
$0.94
52주 변동 폭
$0.2813
$2.82
Harvard Bioscience Inc Stock (HBIO) Company Profile
명칭
Harvard Bioscience Inc
전화
(508) 893-8999
주소
84 OCTOBER HILL RD, HOLLISTON, MA
HBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.63 | 19.88M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
530.02 | 190.57B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
179.38 | 52.03B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
252.26 | 37.01B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.26 | 36.39B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
278.54 | 20.49B | 2.96B | 487.70M | 344.00M | 6.6758 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-09 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | 개시 | Northland Capital | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-01-24 | 재확인 | Janney | Buy |
| 2018-01-23 | 재확인 | The Benchmark Company | Buy |
| 2016-11-17 | 개시 | Singular Research | Buy |
| 2015-07-28 | 개시 | The Benchmark Company | Buy |
모두보기
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience (HBIO) Plunges 84% – Will New CEO & Nasdaq Lifeline Spark a Turnaround? - ts2.tech
Key resistance and support levels for Harvard Bioscience Inc.July 2025 Summary & Proven Capital Preservation Methods - newser.com
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET - The Manila Times
Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 ... - Bluefield Daily Telegraph
Harvard Bioscience (Nasdaq: HBIO) schedules earnings call to discuss Q3 2025 results - Stock Titan
Is Harvard Bioscience Inc. stock a buy before product launchesMarket Sentiment Review & Accurate Buy Signal Alerts - newser.com
Published on: 2025-10-30 04:49:01 - newser.com
Is Harvard Bioscience Inc. stock a contrarian buy2025 Institutional Moves & High Yield Stock Recommendations - newser.com
Will Harvard Bioscience Inc. stock outperform Nasdaq indexJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com
Applying Wyckoff theory to Harvard Bioscience Inc. stock2025 Institutional Moves & Breakout Confirmation Alerts - newser.com
Will Harvard Bioscience Inc. stock benefit from sector rotationJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Can Harvard Bioscience Inc. stock hit analyst price targetsQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
What moving averages say about Harvard Bioscience Inc.July 2025 Short Interest & Weekly Return Optimization Alerts - newser.com
Published on: 2025-10-29 04:22:58 - newser.com
Why Harvard Bioscience Inc. (HBI) stock could break out in 2025Weekly Trade Summary & Reliable Momentum Entry Alerts - Fundação Cultural do Pará
Using fundamentals and technicals on Harvard Bioscience Inc.Weekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Will Harvard Bioscience Inc. (HBI) stock benefit from mergersWeekly Trade Report & AI Enhanced Market Trend Forecasts - newser.com
Why Harvard Bioscience Inc. stock is seen as undervaluedJuly 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Gains Recap: Is Harvard Bioscience Inc. stock a top pick in earnings season2025 Big Picture & Proven Capital Preservation Methods - Fundação Cultural do Pará
What analysts say about Harvard Bioscience Inc stockMarket Volatility Update & High Return Capital Gain - earlytimes.in
Harvard Bioscience Inc (HBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
14.54%
4.94%
자본화:
|
볼륨(24시간):